Better health and ageing for all Australians

About the PBS

How much should I pay?

This section of the website contains information on PBS patient co-payment amounts and product (brand and therapeutic) premiums.

If you are a general patient, from 1 January 2009 you pay up to $32.90 for most prescription medicines supplied through the PBS (concessional patients pay $5.30). These payments, called patient copayments, are revised annually in line with the Consumer Price Index.

Brand premium policy

The PBS subsidises all brands of the same drug to the same amount; that is, up to the cost of the lowest priced brand. A manufacturer may be unwilling to market their brand at the lowest price and will ask that patients pay extra for their brand. The extra amount is called the ‘brand premium’ and it does not count towards the Safety Net threshold. Importantly, there will always be at least one brand without a brand premium. Unless your doctor has specifically indicated otherwise on the prescription, a pharmacist can dispense another brand of the same medicine at your request. In this way, you can avoid paying a brand premium.

Therapeutic group premium policy

Within the PBS there are specifically defined groups of drugs which have similar safety and health outcomes. Within these groups the drugs are considered interchangeable when being prescribed for a patient. The Government subsidises all drugs within a group to the level of the lowest priced drug. The difference in price between the lowest priced drug and higher priced drugs within the group is called a therapeutic group premium. This premium is paid by the patient and does not count towards the Safety Net threshold.

There is always at least one drug within each group of drugs available without a premium. In addition, if you, for a medical reason, are only able to take a drug which has a premium, your doctor can request an exemption from Medicare Australia, for you to obtain that drug without paying the premium.


Special Patient Contributions (other than Brand Premiums or Therapeutic Group Premiums)

Special patient contributions are applied when the manufacturer and the Government cannot agree on the dispensed price. In most cases your doctor can seek an authority from Medicare Australia to waive this patient contribution where there is not clinically suitable alternative listed on the PBS at the lower price. Doctors are encouraged to seek a waiver whenever appropriate so that patients are not financially disadvantaged.